Genital Herpes Counseling: Ethical Considerations in Confidentiality, Disclosure, and Psychosocial Harm.

Genital herpes is a common, recurrent, chronic sexually transmitted infection that is frequently encountered in dermatologic practice, and one in which the psychosocial burden often exceeds the physical, as many affected individuals are asymptomatic or experience only mild symptoms. Shame, fear of rejection, anger, depression, and anxiety surrounding disclosure can diminish quality of life more than the herpes infection's physical manifestations. These concerns are compounded by practical threats to confidentiality, especially for adolescents whose explanation-of-benefits statements are insured under a parent's plan. Using two cases, we examine the ethical tensions that a diagnosis of genital herpes can create for the dermatologist. In the first, a patient requests omission of the diagnosis from her record, and in the second, the same patient declines to notify an identifiable partner. In genital herpes, ethical management requires balancing confidentiality against truthful documentation and the interests of identifiable partners, while attending to stigma, relational autonomy, truthfulness, beneficence, informed consent, and psychologic morbidity alongside antiviral therapy. Genital herpes is a sexually transmitted infection (STI) with a high worldwide prevalence and is frequently encountered by dermatologists1. Uniquely, the psychosocial burden of genital herpes often exceeds that of its physical manifestations, with many patients reporting feelings of shame, embarrassment, fear of rejection, anxiety surrounding disclosure, and concerns regarding future intimate relationships, all of which may substantially affect quality of life.1,2 These psychosocial concerns may be compounded and exacerbated by practical barriers to maintaining confidentiality. For example, adolescents insured under a parent's health plan or a spouse insured under their partner's policy may fear inadvertent disclosure through pharmacy records, billing notifications, or electronic patient portals. Professional organizations, including the Society for Adolescent Health and Medicine, have recognized that explanation of benefits and other insurance communications may compromise confidentiality for adolescents and young adults seeking such sensitive healthcare and continue to emphasize that confidentiality is an essential component of high-quality care for these patients3,4. Although the medical management of genital herpes is generally straightforward, such scenarios illustrate ethical challenges dermatologists may encounter when counseling patients with highly stigmatized conditions. Navigating these situations requires more than treating the viral infection itself; rather, it necessitates thoughtful consideration of confidentiality, truthful documentation, stigma reduction, partner welfare, and compassionate counseling that supports patient autonomy, informed consent, harm reduction (beneficence and non-maleficence), and psychosocial well-being.